LPLearta Pervizaj-Oruqaj

Learta Pervizaj-Oruqaj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Learta Pervizaj-Oruqaj has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Susanne Herold

    Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), German Center for Infection Research (DZIF), Justus-Liebig-University Giessen (JLU), Giessen, Germany

    4 shared publications
  • Werner Seeger

    Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC) Member of the German Center for Lung Research (DZL) Giessen Germany

    4 shared publications
  • Christina Malainou

    Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus Liebig University Giessen

    3 shared publications
  • Jochen Wilhelm

    Institute for Lung Health (ILH), Universities Giessen & Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig-University Giessen, Giessen, Germany

    3 shared publications
  • Maximiliano Ruben Ferrero

    Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL) and the German Center for Infection Research (DZIF), Justus-Liebig University (JLU) Giessen, Giessen, Germany

    3 shared publications
  • Rolf David Glaser

    Cardiopulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Institute for Lung Health (ILH), Member of the German Center for Lung Research (DZL), Justus-Liebig University of Giessen, Germany

    3 shared publications

Latest Publications

  • Open Access

    Mitochondrial COX4I2 drives pericyte-dependent inflammation and emphysema

    by Claudia F. Garcia Castro, Vidya Srokshna Balasubramanian Lakshmi, Stefan Hadzic, Claudio Nardiello, Rolf D. Glaser, Maik Hüttemann, Lawrence I. Grossman, Baktybek Kojonazarov, Muchen Li, Sandipan Jash, et al.

    Chronic obstructive pulmonary disease (COPD) is characterized by neutrophilic inflammation, emphysema, and mild pulmonary hypertension (PH). Oxidative/nitrosative stress are key drivers, but specific mitochondrial mechanisms remain unclear. We show increased expression of the regulatory mitochondrial cytochrome c oxidase subunit 4 isoform 2 (COX4I2) in an early murine model and human COPD. After 8 months of cigarette smoke exposure, Cox4i2 −/− mice were completely protected from emphysema but not from PH, associated with reduced nitrosative stress, inflammation, and apoptosis. Using a novel Cox4i2 reporter mouse and in situ hybridization of human lungs, COX4I2 was detected in precapillary ACTA2 + cells and capillary pericytes. COX4I2 promotes mitochondrial reactive oxygen species (mtROS) production in these cells, thereby enhancing neutrophil migration and alveolar type II cell apoptosis, and modulates angiogenesis. In contrast to Cox4i2 −/− , mitochondria-targeted antioxidant MitoQ reversed emphysema and PH, suggesting pericyte-specific regulation of COPD pathologies and mtROS inhibition as a therapeutic approach in COPD. Graphical

  • Open Access

    Diagnostic yield and histopathological assessment of endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy: a prospective comparison of two tunnelling approaches

    by Gani Oruqaj, Sylvia Lohfink-Schumm, Stefan Gattenloehner, Learta Pervizaj-Oruqaj, Kevin Lo, Gabriele Krombach, Werner Seeger, Friedrich Grimminger, Khodr Tello, Matthias Hecker

    Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for mediastinal and hilar lymph node evaluation, although its diagnostic performance may be limited in rare tumours, benign diseases, lymphoproliferative disorders and for detailed molecular analyses. Data on the role of EBUS-guided transbronchial mediastinal cryobiopsy (EBUS-TMC) remain limited. Methods: We conducted a prospective cohort study in 90 patients undergoing EBUS-TBNA and EBUS-TMC for mediastinal or peribronchial lesions ≥1 cm. Two tunnelling approaches using 22-G (SonoTip TopGain) and 19-G (ViziShot 2 FLEX) TBNA needles were employed. TBNA and cryobiopsy with a 1.1-mm cryoprobe were performed sequentially in the same lymph node. Results: 45 patients were assigned to each group. The diagnostic yield of EBUS-TMC was 91.1% (22-G) and 93.3% (19-G) (p=0.0005 and p=0.006, respectively, versus EBUS-TBNA). For EBUS-TBNA, yields were 68.8% (22-G) and 77.7% (19-G) (p=0.28). Diagnostic yield improved significantly between TBNA and TMC for both 22-G (p=0.0005) and 19-G (p=0.006). Mean± sem procedure time was 25.1±3.9 min (22-G) versus 26.7±5.3 min (19-G) (p=0.11) and sample size was 3.5±0.9 mm (22-G) versus 3.6±1.1 mm (19-G) (p=0.76). Needle switching from 19-G to 22-G was required in two patients due to anatomical constraints. Re-tunnelling was performed in two (22-G) and four (19-G) patients. No severe bleeding or complications were observed. Conclusions: EBUS-TMC is a safe, feasible and minimally invasive method with superior diagnostic yield and histological quality compared to EBUS-TBNA. Both 22-G and 19-G approaches are effective; 22-G is more adaptable for distal targets, while 19-G is suited for centrally located or accessible lesions. Combining EBUS-TBNA and EBUS-TMC may further enhance diagnostic accuracy in complex cases.


  • Cell type–specific efferocytosis determines functional plasticity of alveolar macrophages

    by Julian Better, Mohammad Estiri, Michael Wetstein, Learta Pervizaj-Oruqaj, Christina Malainou, Victoria Ogungbemi-Alt, Maximiliano Ruben Ferrero, Martin Langelage, Irina Kuznetsova, Ana Ivonne Vazquez-Armendariz, et al.

    Resolution of lung injuries is vital to maintain gas exchange, but there is an increased risk of secondary bacterial infections during this stage. Alveolar macrophages (AMs) are crucial to clear bacteria and control the resolution of inflammation, but environmental cues that switch functional phenotypes of AMs remain incompletely understood. Here, we found that AMs lack the capacity to mount an effective immune response against bacteria during resolution of inflammation. Neutrophil (PMN)–derived myeloperoxidase (MPO) fueled canonical glutaminolysis via the mitochondrial membrane transporter uncoupling protein–2 (UCP2), resulting in decreased mtROS-dependent killing of bacteria and secretion of pro-inflammatory cytokines. MPO-enhanced UCP2 expression inhibited mitochondrial hyperpolarization and boosted efferocytosis irrespective of the presence of bacterial pathogens. Conversely, efferocytosis of other cell types resulted in a distinct anti-inflammatory AM phenotype while maintaining antibacterial phenotypic plasticity. Overall, our findings indicate that the uptake of apoptotic PMNs or MPO switches AMs to prioritize resolution of inflammation over antibacterial responses, a feature that is conserved in murine extrapulmonary macrophages and human AMs.


  • Open Access

    The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis

    by Learta Pervizaj-Oruqaj, Maximiliano Ruben Ferrero, Ulrich Matt, Susanne Herold

    Recent breakthroughs in single-cell sequencing, advancements in cellular and tissue imaging techniques, innovations in cell lineage tracing, and insights into the epigenome collectively illuminate the enigmatic landscape of alveolar macrophages in the lung under homeostasis and disease conditions. Our current knowledge reveals the cellular and functional diversity of alveolar macrophages within the respiratory system, emphasising their remarkable adaptability. By synthesising insights from classical cell and developmental biology studies, we provide a comprehensive perspective on alveolar macrophage functional plasticity. This includes an examination of their ontology-related features, their role in maintaining tissue homeostasis under steady-state conditions and the distinct contribution of bone marrow-derived macrophages (BMDMs) in promoting tissue regeneration and restoring respiratory system homeostasis in response to injuries. Elucidating the signalling pathways within inflammatory conditions, the impact of various triggers on tissue-resident alveolar macrophages (TR-AMs), as well as the recruitment and polarisation of macrophages originating from the bone marrow, presents an opportunity to propose innovative therapeutic approaches aimed at modulating the equilibrium between phenotypes to induce programmes associated with a pro-regenerative or homeostasis phenotype of BMDMs or TR-AMs. This, in turn, can lead to the amelioration of disease outcomes and the attenuation of detrimental inflammation. This review comprehensively addresses the pivotal role of macrophages in the orchestration of inflammation and resolution phases after lung injury, as well as ageing-related shifts and the influence of clonal haematopoiesis of indeterminate potential mutations on alveolar macrophages, exploring altered signalling pathways and transcriptional profiles, with implications for respiratory homeostasis.


  • Top Cited Papers
    Open Access

    Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia

    by Learta Pervizaj-Oruqaj, Balachandar Selvakumar, Maximiliano Ruben Ferrero, Monika Heiner, Christina Malainou, Rolf David Glaser, Jochen Wilhelm, Marek Bartkuhn, Astrid Weiss, Ioannis Alexopoulos, et al.

    Influenza A virus (IAV) infection mobilizes bone marrow-derived macrophages (BMDM) that gradually undergo transition to tissue-resident alveolar macrophages (TR-AM) in the inflamed lung. Combining high-dimensional single-cell transcriptomics with complex lung organoid modeling, in vivo adoptive cell transfer, and BMDM-specific gene targeting, we found that transitioning (“regenerative”) BMDM and TR-AM highly express Placenta-expressed transcript 1 (Plet1). We reveal that Plet1 is released from alveolar macrophages, and acts as important mediator of macrophage-epithelial cross-talk during lung repair by inducing proliferation of alveolar epithelial cells and re-sealing of the epithelial barrier. Intratracheal administration of recombinant Plet1 early in the disease course attenuated viral lung injury and rescued mice from otherwise fatal disease, highlighting its therapeutic potential.